aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, George Papatheodoridis et al.|Journal of Hepatology|2020Cited by 346
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatmentYameng Sun, Jidong Jia, Jialing Zhou et al.|Hepatology|2016Cited by 156
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During TherapyYameng Sun, Hong You, Xiaoning Wu et al.|Clinical Gastroenterology and Hepatology|2020Cited by 115
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Seng Gee Lim, Changhyeong Lee et al.|Clinical Gastroenterology and Hepatology|2019Cited by 111
Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External ValidationShanshan Wu, Hwai‐I Yang, Na Zeng et al.|Clinical Gastroenterology and Hepatology|2021Cited by 64